Non-small cell carcinoma: Comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations

European Journal of Radiology

Volumn 79, Issue 3, 2011, Pages 473-479

  Onishi, Yumiko ^a   Ohno, Yoshiharu ^a   Koyama, Hisanobu ^a   Nogami, Munenobu ^a   Takenaka, Daisuke ^a   Matsumoto, Keiko ^a,b   Yoshikawa, Takeshi ^a   Matsumoto, Sumiaki ^a   Maniwa, Yoshimasa ^a   Nishimura, Yoshihiro ^a   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

CT; Lung cancer; PET; Recurrence; Surgery; Survival

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STANDARD;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROC CURVE; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 80052267559     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.04.027     Document Type: Article

References (37)

1. N. Martini, M.S. Bains, and M.E. Burt Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
2. K. al-Kattan, E. Sepsas, S.W. Fountain, and E.R. Townsend Disease recurrence after resection for stage I lung cancer Eur J Cardiothorac Surg 12 1997 380 384 (Pubitemid 27397975)
3. J. Martin, R.J. Ginsberg, and E.S. Venkatraman Long-term results of combined-modality therapy in resectable non-small-cell lung cancer J Clin Oncol 20 2002 1989 1995 (Pubitemid 34408788)
4. R.J. Hicks, V. Kalff, and M.P. MacManus The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification J Nucl Med 42 2001 1605 1613 (Pubitemid 33131318)
5. K.B. Roberts, M.P. Manus, and R.J. Hicks PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy Lung Cancer 47 2005 49 57 (Pubitemid 39643241)
6. Z. Keidar, N. Haim, and L. Guralnik PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management J Nucl Med 4 5 2004 1640 1646 (Pubitemid 47618469)
7. R. Hustinx, F. Benard, and A. Alavi Whole-body FDG-PET imaging in the management of patients with cancer Semin Nucl Med 32 2002 35 46 (Pubitemid 34112941)
8. D. Lardinois, W. Weder, and T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507 (Pubitemid 36706537)
9. R.J. Cerfolio, B. Ojha, A.S. Bryant, V. Raghuveer, J.M. Mountz, and A.A. Bartolucci The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 2004 1017 1023 (Pubitemid 39164825)
10. B.S. Halpern, C. Schiepers, and W.A. Weber Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion Chest 128 2005 2289 2297 (Pubitemid 41507571)
11. Y. Nakamoto, M. Senda, and T. Okada Software-based fusion of PET and CT images for suspected recurrent lung cancer Mol Imaging Biol 10 2008 147 153
12. H. Svanholm, H. Starklint, H.J. Gundersen, J. Fabricius, H. Barlebo, and S. Olsen Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic APMIS 97 1989 689 698 (Pubitemid 19217684)
13. S.J. Swensen, L.R. Brown, T.V. Colby, A.L. Weaver, and D.E. Midthum Lung nodule enhancement at CT: prospective findings Radiology 201 1996 447 455 (Pubitemid 26357642)
14. Y. Ohno, H. Hatabu, D. Takenaka, S. Adachi, M. Kono, and K. Sugimura Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience Radiology 224 2002 503 511 (Pubitemid 34809134)
15. Y. Ohno, H. Hatabu, and D. Takenaka Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging Radiology 231 2004 872 879 (Pubitemid 38668111)
16. S.L. Aquino, L.B. Kuester, V.V. Muse, E.F. Halpern, and A.J. Fischman Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT Eur J Nucl Med Mol Imaging 33 2006 692 696 (Pubitemid 43846760)
17. G.S. Meirelles, Y.E. Erdi, and S.A. Nehmeh Deep-inspiration breath-hold PET/CT: clinical findings with a new technique for detection and characterization of thoracic lesions J Nucl Med 48 2007 712 719 (Pubitemid 47604970)
18. E.M. Rohren, J.M. Provenzale, D.P. Barboriak, and R.E. Coleman Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy Radiology 226 2003 181 187 (Pubitemid 36163927)
19. L.K. Griffeth, K.M. Rich, and F. Dehdashti Brain metastases from non-central nervous system tumors: evaluation with PET Radiology 186 1993 37 44 (Pubitemid 23005464)
20. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332 (Pubitemid 38552885)
21. E.F. Patz Jr. , V.J. Lowe, and J.M. Hoffman Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490 (Pubitemid 23216276)
22. N.A. Dewan, N.C. Gupta, L.S. Redepenning, J.J. Phalen, and M.P. Frick Diagnostic efficiency of PET-FDG imaging in solitary pulmonary nodules Chest 104 1993 997 1002
23. J.P. Lamont, J.T. Kakuda, and D. Smith Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA Arch Surg 137 2002 935 938
24. K. Kuriyama, M. Seto, and T. Kasugai Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung Am J Roentgenol 173 1999 465 469 (Pubitemid 29347378)
25. T. Aoki, H. Nakata, and H. Watanabe Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time Am J Roentgenol 174 2000 763 798
26. T. Aoki, Y. Tomoda, and H. Watanabe Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival Radiology 220 2001 803 809 (Pubitemid 32799993)
27. S. Oda, K. Awai, and D. Liu Ground-glass opacities on thin-section helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia Am J Roentgenol 190 2008 1363 1368 (Pubitemid 351684900)
28. J. Collins, and E.J. Stern Ground-glass opacity at CT: the ABCs Am J Roentgenol 169 1997 355 367 (Pubitemid 27334842)
29. American Society of Clinical Oncology Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology J Clin Oncol 15 1997 2996 3018
30. W.T. Sause, R.W. Byhardt, and W.J. Curran Jr. Follow-up of non-small cell lung cancer. American College of Radiology. ACR appropriateness criteria Radiology 215 2000 S1363 S1372
31. G.L. Colice, J. Rubins, and M. Unger American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative-intent therapy Chest 123 2003 S272 S283
32. J. Rubins, M. Unger, and G.L. Colice American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) Chest 132 2007 S355 S367
33. D. Hellwig, A. Gröschel, and T.P. Graeter Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer Eur J Nucl Med Mol Imaging 33 2006 13 21 (Pubitemid 41785304)
34. J.W. Fletcher, B. Djulbegovic, and H.P. Soares Recommendations on the use of 18F-FDG PET in oncology J Nucl Med 49 2008 480 508 (Pubitemid 351355215)
35. T. Morimoto, U. Tateishi, T. Maeda, Y. Arai, Y. Nakajima, and E. Edmund Kim Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: comparison of integrated PET/CT with or without contrast enhancement Eur J Radiol 67 2008 508 513
36. K. Strobel, S. Heinrich, and U. Bhure Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer J Nucl Med 49 2008 1408 1413
37. K. Kitajima, K. Murakami, and E. Yamasaki Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT Eur J Nucl Med Mol Imaging 36 2009 1388 1396